Alkermes plc.

By person

30 insiders · 295 transactions

52.8×

Richard F. Pops holds 52.8 times base salary in stock. $66.15M of shares against $1.25M in salary for 2025.

Salary from the company's own proxy. The shares are what Richard F. Pops last reported holding, valued at $48.01, the price Ordinary Shares was last bought or sold at on the open market here, on 3 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

POPS RICHARD F

Director and CEO, Alkermes plc

—

$62.69M (47) scheduled

−$62.69M

1,377,740

0.8212%

$66.15M

+130.2%

Hopkinson Craig C.

EVP R&D, Chief Medical Officer

—

$24.75M (30) scheduled

−$24.75M

65,389

0.0390%

$3.14M

—

LANDINE MICHAEL J

SVP, Corp Dev., Alkermes, Inc.

—

$14.45M (30) scheduled

−$14.45M

281,730

0.1679%

$13.53M

+84.1%

Cooke Shane

Director

—

$12.24M (24) scheduled

−$12.24M

106,679

0.0636%

$5.12M

+76.8%

FRATES JAMES M

SVP, Alks Inc; CFO ALKS

—

$7.08M (11) scheduled

−$7.08M

91,828

0.0547%

$4.41M

+304.2%

Ehrich Elliot

EVP, R&D & CMO, Alkermes, Inc.

—

$4.53M (15) scheduled

−$4.53M

57,056

0.0340%

$2.74M

+25.9%

BIBERSTEIN KATHRYN L

EVP/CAO/CCO/CRO Alks Inc;

—

$3.20M (11) scheduled

−$3.20M

40,200

0.0240%

$1.93M

—

Brown Iain Michael

SVP, Chief Financial Officer

—

$2.58M (5) scheduled

−$2.58M

148,196

0.0883%

$7.11M

+779.8%

Jackson Blair Curtis

President & CEO, Alkermes plc

—

$2.25M (2) scheduled

−$2.25M

241,308

0.1438%

$11.59M

+312.3%

snyderman nancy lynn MD

Director

$10.00K (1)

$2.24M (1) scheduled

−$2.23M

15,395

0.0092%

$739.11K

—

Nichols Christian Todd

SVP, Chief Commercial Officer

—

$2.20M (9) scheduled

−$2.20M

102,193

0.0609%

$4.91M

—

MITCHELL PAUL J

Director

—

$2.05M (30) scheduled

−$2.05M

18,174

0.0108%

$872.53K

+127.2%

Gaffin David Joseph

EVP, CLO, Alkermes, Inc.

—

$2.01M (15) scheduled

−$2.01M

223,422

0.1332%

$10.73M

+993.4%

Stejbach Mark

SVP/Chief Comm Off, Alks Inc

—

$1.97M (6) scheduled

−$1.97M

51,065

0.0304%

$2.45M

+91.6%

BREYER ROBERT A

Director

—

$1.68M (3)

−$1.68M

10,330

0.0062%

$495.94K

−70.6%

Pugh Gordon G

SVP, COO & CRO, Alkermes, Inc.

—

$1.24M (2) scheduled

−$1.24M

59,324

0.0354%

$2.85M

−9.5%

ANSTICE DAVID W

Director

—

$1.22M (6) scheduled

−$1.22M

84,905

0.0506%

$4.08M

+466.0%

Parisi Samuel Joseph

VP, Finance (Interim PAO)

—

$1.21M (6) scheduled

−$1.21M

7,717

0.0046%

$370.49K

+97.9%

DIXON WENDY L

Director

—

$1.13M (2) scheduled

−$1.13M

53,124

0.0317%

$2.55M

+3,220%

Wysenski Nancy

Director

$278.71K (3)

$1.29M (1) scheduled

−$1.01M

31,598

0.0188%

$1.52M

—

BLOOM FLOYD E

Director

—

$879.02K (1)

−$879.02K

127,923

0.0763%

$6.14M

0.0%

Daglio David Angelo Jr.

Director

$815.73K (1)

—

+$815.73K

107,780

0.0642%

$5.17M

+139.5%

LAURENCIN CATO T

Director

—

$343.61K (4) scheduled

−$343.61K

33,769

0.0201%

$1.62M

—

MCKEON BRIAN P

Director

$264.27K (1)

—

+$264.27K

48,536

0.0289%

$2.33M

—

Wright Christopher I

Director

—

$90.20K (1) scheduled

−$90.20K

25,680

0.0153%

$1.23M

—

Alva Emily Peterson

Director

$49.86K (1)

—

+$49.86K

27,302

0.0163%

$1.31M

—

Wilson Frank Anders

Director

—

35,751

0.0213%

$1.72M

—

GAYNOR RICHARD

Director

—

35,751

0.0213%

$1.72M

—

Lurker Nancy

Director

—

18,222

0.0109%

$874.84K

—

Robinson James A. Jr.

President & COO,Alkermes, Inc.

—

4,412

0.0026%

$211.82K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Parisi Samuel Joseph

27 Feb 2024

VP, Finance (Interim PAO)

Sell

2,559

$29.65

$75.87K

Nichols Christian Todd

21 Jun 2022

SVP, Chief Commercial Officer

Sell

7,474

$28.26

$211.20K

Hopkinson Craig C.

23 Feb 2022

EVP R&D, Chief Medical Officer

Sell

11,983

$24.76

$296.65K

Hopkinson Craig C.

18 Feb 2022

EVP R&D, Chief Medical Officer

Sell

2,306

$25.17

$58.04K

Hopkinson Craig C.

9 Jun 2021

EVP R&D, Chief Medical Officer

Sell

882

$24.60

$21.70K

Hopkinson Craig C.

15 Apr 2021

EVP R&D, Chief Medical Officer

Sell

28,920

$19.72

$570.29K

BLOOM FLOYD E

16 Jul 2018

Director

Sell indirect

20,000

$43.95

$879.02K

FRATES JAMES M

12 Jun 2018

SVP, Alks Inc; CFO ALKS

Sell

16,842

$50.00

$842.18K

Brown Iain Michael

29 Dec 2017

SVP Finance & CAO, Alks Inc.

Sell

10,652

$54.81

$583.89K

BREYER ROBERT A

2 Mar 2017

Director

Sell

4,000

$60.00

$240.00K

Ehrich Elliot

15 Feb 2017

EVP, R&D & CMO, Alkermes, Inc.

Sell

1,000

$58.17

$58.17K

BREYER ROBERT A

4 Jan 2017

Director

Sell

4,000

$60.00

$240.00K

Showing 250 of 295 transactions. The figures above use every one of them.

By person

Individual transactions

What was left out